Framework Contracts to speed up the development of and access to innovative medical countermeasures - Next-generation influenza vaccines

HaDEA has published the EU4Health Prior Information Notice HADEA/2025/CPN/0008-PIN - Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures - Next-Generation Influenza Vaccines.

This call for tenders will aim to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms (e.g. nucleic acid approaches and/or production in scalable eukaryotic or bacterial cell culture, in plants or via in vitro transcription), could support products utilising novel administration routes (e.g. nasal, oral or through microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses, which are protective across influenza subtypes or across alpha-influenza viruses, and/or possess intrinsic immunogenicity without the addition of adjuvants.

Fill in the online public Consultation on Pre-Commercial Procurement (PCP) for next generation influenza vaccine development by 5 March.